Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Researchers from Oxford’s Nuffield Department of Clinical Neurosciences and Department of Experimental Psychology have shown that people who have had COVID but don’t complain of long COVID symptoms in daily life nevertheless can show degraded attention and memory for up to six to nine months.

Person writing notes

Previous studies have shown that after acute COVID-19 infection some people can continue to suffer from cognitive symptoms such as difficulties in concentrating, colloquially referred to as brain fog, as well as forgetfulness and fatigue – features of the 'long COVID' syndrome.

But it was not known whether cognitive performance can also be affected in individuals who had mild symptoms and report no concerns after recovery from acute COVID infection.

We still do not understand the mechanisms that cause these cognitive deficits, but it is very encouraging to see that these attention and memory impairments return largely to normal in most people we tested by 6-9 months after infection, who demonstrated good recovery over time.
- Professor Masud Husain

In this study, participants were asked to complete a number of exercises to test their memory and cognitive ability, with a focus on cognitive functions critical for daily life, such as sustaining attention, memory, planning and semantic reasoning.

All the participants had previously suffered from COVID-19 but were not significantly different from a control group at the time of testing on factors such as fatigue, forgetfulness, sleep patterns or anxiety.

The researchers found that the participants performed well in most abilities tested, including working memory and planning, but they displayed significantly worse episodic memory (up to six months post-COVID infection) and a greater decline in the ability to sustain attention over time (for up to nine months) than uninfected individuals.

Dr Sijia Zhao of the Department of Experimental Psychology, University of Oxford, said: 'What is surprising is that although our COVID-19 survivors did not feel any more symptomatic at the time of testing, they showed degraded attention and memory. Our findings reveal that people can experience some chronic cognitive consequences for months.'

Read the full paper.

Similar stories

Insights into the molecular pathways of progressive multiple sclerosis

Text by Ian Fyfe for 'Nature Reviews Neurology'

Discovery of gene involved in chronic pain creates new treatment target

Our researchers have discovered a gene that regulates pain sensitisation by amplifying pain signals within the spinal cord. This is helping them to understand an important mechanism underlying chronic pain in humans, and provides a new treatment target.

Lymph nodes reveal more about mechanisms of autoimmunity

Two recent papers show that studying lymph nodes reveals details of the mechanisms of autoimmunity.

Multiple heart-related conditions linked to triple dementia risk, regardless of genetics

Having multiple conditions that affect the heart is linked to a greater risk of dementia than having high genetic risk, according to a large-scale new study.

NDCN research presented at Myasthenia Gravis conference

The 14th Quinquennial Myasthenia Gravis Federation of America International Conference was recently held in Miami with 450 delegates attending in person, including over 100 from industry.

Magnetic signatures of the brain characterised in UK Biobank imaging study

A study published this week in Nature Neuroscience demonstrates how studying the magnetic properties of tissue may provide a unique window into brain health and disease.